UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm

Therapeutic Advances in Medical Oncology, 2013-03, Vol.5 (2), p.105-118

2013

Link zum Volltext

Verfügbarkeit prüfen

Mixed Messages: I. The Consequences of Communicating Negative Statements Within Emotional Support Messages to Cancer Patients

Journal of patient experience, 2020-08, Vol.7 (4), p.593-599

2020

Link zum Volltext

Verfügbarkeit prüfen

Current and future systemic treatments for renal cell carcinoma

Seminars in cancer biology, 2013-02, Vol.23 (1), p.38-45

2013

Link zum Volltext

Verfügbarkeit prüfen

Chromophobe renal cell carcinoma with prolonged response to sequential sunitinib and everolimus

Journal of clinical oncology, 2011-03, Vol.29 (9), p.e241-e242

2011

Link zum Volltext

Verfügbarkeit prüfen

Endobronchial metastases from renal cell carcinoma: A late manifestation of the disease with an increasing incidence

BJU international, 2012-11, Vol.110 (10), p.1407-1408

2012

Link zum Volltext

Verfügbarkeit prüfen

Treatment of brain metastases in patients with melanoma

The lancet oncology, 2012-05, Vol.13 (5), p.434-435

2012

Link zum Volltext

Verfügbarkeit prüfen

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Nature medicine, 2019-06, Vol.25 (6), p.936-940

2019

Link zum Volltext

Verfügbarkeit prüfen

Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

Nature medicine, 2019-06, Vol.25 (6), p.941-946

2019

Link zum Volltext

Verfügbarkeit prüfen

Subsidised access to new melanoma drugs : in need of further innovation?

New Zealand medical journal, 2016-08, Vol.129 (1440), p.37-54

2016

Link zum Volltext

Verfügbarkeit prüfen

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Cell, 2018-04, Vol.173 (3), p.595-610.e11

2018

Link zum Volltext

Verfügbarkeit prüfen

Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib

Radiology, 2014-11, Vol.273 (2), p.452

2014

Link zum Volltext

Verfügbarkeit prüfen

Parallel evolution of tumour subclones mimics diversity between tumours

The Journal of pathology, 2013-08, Vol.230 (4), p.356-364

2013

Link zum Volltext

Verfügbarkeit prüfen

Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution

Nature communications, 2015-03, Vol.6 (1), p.6336-6336, Article 6336

2015

Link zum Volltext

Verfügbarkeit prüfen

Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma

European journal of cancer (1990), 2021-11, Vol.158, p.156-168

2021

Link zum Volltext

Verfügbarkeit prüfen

Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma

Cancer management and research, 2012, Vol.4 (default), p.243-252

2012

Link zum Volltext

Verfügbarkeit prüfen

Ipilimumab activity in advanced uveal melanoma

Melanoma research, 2013-02, Vol.23 (1), p.79-81

2013

Link zum Volltext

Verfügbarkeit prüfen

Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas

The Journal of pathology, 2013-12, Vol.231 (4), p.424-432

2013

Link zum Volltext

Verfügbarkeit prüfen

Individualising treatment choices in a crowded treatment algorithm

European journal of cancer supplements, 2013-09, Vol.11 (2), p.160-168

2013

Link zum Volltext

Verfügbarkeit prüfen

Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to sunitinib

Journal of clinical oncology, 2010-10, Vol.28 (28), p.e539-e540

2010

Link zum Volltext

Verfügbarkeit prüfen

Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Nature medicine, 2019-08, Vol.25 (8), p.1319-1319

2019

Link zum Volltext

Verfügbarkeit prüfen

Survey of Australasian clinicians' prior beliefs concerning lipiodol flushing as a treatment for infertility: A Bayesian study

Australian & New Zealand journal of obstetrics & gynaecology, 2006-08, Vol.46 (4), p.298-304

2006

Link zum Volltext

Verfügbarkeit prüfen

Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenib

Melanoma research, 2016-04, Vol.26 (2), p.138-144

2016

Link zum Volltext

Verfügbarkeit prüfen

New targeted therapies for renal cell carcinoma

Expert opinion on investigational drugs, 2011-07, Vol.20 (7), p.933-945

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(66)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(45)
Humans
(35)
Oncology
(20)
Female
(17)
Male
(16)
Middle Aged
(14)
Adult
(11)
Aged
(9)
Clinical Neurology
(9)
Melanoma
(9)
Neurosciences & Neurology
(9)
Immunotherapy
(8)
Melanoma - Drug Therapy
(7)
Carcinoma, Renal Cell - Drug Therapy
(6)
Carcinoma, Renal Cell - Genetics
(6)
Carcinoma, Renal Cell - Pathology
(6)
Hematology, Oncology And Palliative Medicine
(6)
Ipilimumab
(6)
Kidney Neoplasms - Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm

Mixed Messages: I. The Consequences of Communicating Negative Statements Within Emotional Support Messages to Cancer Patients

Current and future systemic treatments for renal cell carcinoma

Chromophobe renal cell carcinoma with prolonged response to sequential sunitinib and everolimus

Endobronchial metastases from renal cell carcinoma: A late manifestation of the disease with an increasing incidence

Treatment of brain metastases in patients with melanoma

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

Subsidised access to new melanoma drugs : in need of further innovation?

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib

Parallel evolution of tumour subclones mimics diversity between tumours

Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution

Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma

Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma

Ipilimumab activity in advanced uveal melanoma

Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas

Individualising treatment choices in a crowded treatment algorithm

Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution

Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to sunitinib

Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Survey of Australasian clinicians' prior beliefs concerning lipiodol flushing as a treatment for infertility: A Bayesian study

Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenib

New targeted therapies for renal cell carcinoma

Suchergebnisse filtern